Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

FDA approves Santen's levofloxacin eyedrops

Aug. 22, 2000

New compounds interacting with glutathione reductase useful for cataracts, etc.

Aug. 21, 2000

QLT and Ciba Vision seek expanded labeling for Visudyne

Aug. 18, 2000

Bausch & Lomb and Muro to copromote Optivar

Aug. 16, 2000

Retinoid supplementation improves mouse model of childhood blindness

Aug. 11, 2000

FDA approves Rescula for treatment of glaucoma

Aug. 7, 2000

Visudyne approved in E.U. for treatment of wet AMD

Aug. 1, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...